Clinical Presentations
VEITH 2024
MicroNet-Covered Anti-Embolic Stent in Consecutive Increased-Risk Iliac Artery Stenotic Lesions to Reconstruct Anatomy and Guard The Flow: A Multi-Center, Multi-Specialty Study FLOWGUARD-ILIAC NCT04461717
TCT 2024
“Multi-Center Study of the MicroNET-Covered Stent in Consecutive Patients with Acute Carotid-Related Stroke: SAFEGUARD-STROKE”
TCT 2024
“Where Does Interventional Cardiologist Fit in Advancing Interventional Treatment of Stroke?” Piotr Musialek, Jagiellonian University Dept. of Cardiac & Vascular Diseases St. John Paul II Hospital, Krakow, Poland
VEITH 2024
Can Mesh Covered Stents Replace Stent-Grafts For The Treatment Of Complex Iliac Occlusive Lesions: Advantages And Disadvantages Piotr Myrcha, I Chair and Clinic of General and Vascular Surgery,Faculty of Medicine, Medical University of Warsaw, Head of Department of General, Vascular and Oncological Surgery, Mazovian BrodnowskiHospital, Warsaw,Poland
VEITH 2024
“Update On All Trial Results With CGuard And CGuard Prime MicroMesh Covered Stents (InspireMD): Are They Making A Difference And Limitations With Transfemoral/Transradial CAS: Evidence Summary And Long-Term Outcomes” Piotr Musialek, Jagiellonian University Dept. of Cardiac & Vascular Diseases St. John Paul II Hospital, Krakow, Poland
VILNIUS VASCULAR SYMPOSIUM
Carotid Anti-Embolic (’Mesh’) Stent: Optimal Endovascular Therapy Piotr Musialek Jagiellonian University Dept. of Cardiac & Vascular Diseases John Paul II Hospital, Kraków, Poland
LINNC 2024
LINNC 2024 Tandem Lesions: How I manage these cases and European experience with the CGuard CAS system Dr. Adnan H. Siddiqui MD Phd, Chief Executive Officer & CMO Jacobs Institute
CGuard Micronet™ mesh covered stent in asymptomatic carotidstenosis: a vascular center experience
Forcella E, Mastrorilli D, Miccoli T, Pruner G, Bedetti M, Garriboli L
Carotid artery stenting with flow inversion cerebral protection and Micronet covered stent
T. Castrucci, A. Sciarra, A. Siani, F. Accrocca, G. Ianni, R. Cancellieri, R. Gandini, S. Vona, A. Borlizzi, S. Bartoli
The dual-layer CGuardstent is safe and effective in emergent carotid artery stenting and in tandem occlusions: a multi-centric study
Dr. med Mousa Zidan Prof. Dr. Franziska Dorn Department of Neurology, Bonn University Hospital, Germany
CGuard™ short-term safety and long-term efficacy from a single-center prospective registry
GianbattistaParlani, Romano Lydia, Giacomo Isernia, Del MastroFrancesco Pio, Gioele Simonte Vascular & Endovascular Surgery S Maria Misericordia Hospital, Perugia, Italy
CAS with flow reversal cerebral protection and CGuardstent-brachial access-
Tommaso Castrucci UOC ChirurgiaVascolare OspedaleSant‘Eugenio-Roma
Tommaso Castrucci UOC ChirurgiaVascolare OspedaleSant‘Eugenio-Roma
Adnan H. Siddiqui, MD PhD Chief Executive Officer & Chief Medical Officer, Jacobs Institute UB Distinguished Professor & Vice Chair, Department of Neurosurgery Director, Canon Stroke & Vascular Research Center SUNY University at Buffalo Director, Neurosurgical Stroke Service Kaleida Health
Carotid Revascularization 2024: Key Factors to Consider
LINC 2024
1 year Outcomes of the C- GUARDIANS Pivotal IDE Trial of the C-GUARD MicroNet Stent Chris Metzger, MD On Behalf of the C-GUARDIANS Investigators
CX International Symposium 2024
Optical Coherence Tomography analysis of CAS and the benefits of micromesh stent design Gianmarco de Donato Full Professor of Vascular Surgery Chief, Vascular Surgery Unit & Vascular Surgery Residency Program University of Siena, Italy
CX International Symposium 2024
Anti-embolic stent CAS vs single-layer stent CAS vs CEA Piotr Musialek, MD DPhil Jagiellonian University Dept. of Cardiac & Vascular Diseases, John Paul II Hospital, Kraków, Poland
ICI Meeting 2024
2nd Generation (Anti Embolic Stent) CAS vs. CEA, Prof. Piotr Musialek
CGuard Symposium at PVI 2023
CAS Today: Increased Relevance & Access Strategies
Cracow Vascular Summit 2024
The MicroNet™ Covered Stent: What is NEW in 2023/2024 Prof. Piotr Musialek
VIVA 2023
30-Day Results of the C-GUARDIANS Pivotal Trial of the C-Guard Carotid Stent System The C-GUARDIANS Trial D. Christopher Metzger, MD, OhioHealth Riverside Methodist Hospital, Columbus, Ohio, USA on On Behalf of the C-GUARDIANS Investigators
TCT 2023
Staying Safe: Review of Protection in CAS | Prof. Piotr Musialek
TCT 2023
LINC 2023
Acute Stroke of CArotid Artery Bifurcation Origin Treated With Use oF the MicronEtcovered CGUARD Stent (SAFEGUARD-STROKE, NCT05195658)
LINC 2023
Feasibility, Safety, and Efficacyof MicroNet-covered stent in consecutive increased-risk iliac stenoticlesions to reconstructanatomyand guard effective flow: A multi-center, multi-specialty studyFLOWGUARD-ILIAC, NCT04461717 - PiotrPaluszekon behalf of FLOWGUARD-ILIAC Investigators, Dept. of VascularSurgeryand Endovascular Interventions John Paul II Hospital, Krakow
LINC 2023
OCT Analysis of CAS Cases –The Benefits of MicroNet™ - Gianmarco de Donato Full Professor of Vascular Surgery, University of Siena-Italy
PCR 2023
CAS: State-of-the-Art – Piotr Musialek, MD DPhil Jagiellonian University Dept. of Cardiac & Vascular Diseases, John Paul II Hospital, Kraków, Poland
VEITH 2022
Results From A Multicenter Italian Study Of The C-Guard Micromesh Stent For CAS: Advantages And Complications | Francesco Speziale, MD
VEITH 2022
The 3 Micromesh Stents and Their Value In CAS: Do the Design Differences Matter? & Update On Carotid And Other Uses of the MicroNet™-Covered Stent (C-Guard) | Dr. Piotr Musialek and Dr. Max Amor
VEITH 2022
The C-GUARDIANS IDE Trial for the CGuard MicroNet™ Stent, and Context from Longer term European Data | Chris Metzger, MD
TCT 2022
Carotid Artery Endovascular Reconstruction Using MicroNet™-Covered Stents in Patients with Symptoms or Signs of Cerebral Ischemia – Piotr Musialek, MD DPhil for CGuard OPTIMA Investigations
LINC 2022
Randomized Controlled Trial of a First-Generation Carotid Stent versus MicroNet™-Covered Stent: 12-month outcomes - Savr Bugurov, MD
LINC 2022
Stent properties and vessel adaptability: Could these factors influence procedural outcomes? – Matteo Stefanini, MD
LINC 2022
MicroNet™-covered stent in stroke prevention and treatment: New evidence – Piotr Musialek, MD
VEITH 2021
New Multicenter Data Showing the Long-Term Value of the C-Guard MicroNet™ Covered Stent for High Risk Lesions (Thrombotic, Calcified and Symptomatic): From the Flow-Guard and Other Trials Drs. Piotr Musialek, Christopher Metzger
TCT 2021
Carotid artery revascularization using second generation stents versus surgery: A meta-analysis of clinical outcomes Dr. A. Mazurek, et al.
TCT 2021
Cardiology Cathlab-Based Management of Thrombotic Carotid Stenoses in Acute Ischaemic Stroke en Route to a Full Interventional Stroke Service - Tools, Techniques, Local Stroke Unit Collaboration: Challenges and Patient Outcomes Prof. Piotr Musialek, et al.
ESC 2021
One-Year Results from a Prospective Experience on CAS Using the Cguard Stent System: THE IRONGUARD -2 STUDY Pasqualino Sirignano, MD on behalf of the IRONGUARD2 study Group
LINC 2021
CGuard MicroNet™ – covered Stent in Primary and Secondary Stroke Prevention. Piotr Musiałek, MD
LINC 2021
“The safety and effectiveness of carotid revascularization with the Acculink stent and the CGuard stent. Independent randomized study”. Drs. Savr Bugurov, Andrey Karpenko, Pavel Ignatenko
LINC 2021
Carotid artery revascularization: A systematic review and meta-analysis comparing clinical outcomes of second vs. first generations stents. Adam Mazurek MD, PHD on behalf of CARMEN Collaborators
LINC 2021
12 months results from a prospective real-world multicenter clinical practice of CAS using the CGuard EPS: the IRONGUARD 2 study. Pasqualino Sirignano, MD
SVS ONLINE 2020
Results from a prospective real-world multicentre clinical practice of CAS using the CGuard embolic prevention system: the IRONGUARD 2 study – Pasqualino Sirignano, MD
ESC 2020
“ESC Essential Update 2020 Carotid Disease “- Piotr Musiałek, MD DPh FESC Jagiellonian University Department of Cardiac & Vascular Disease
PCR eCourse 2020
The SIBERIA trial for carotid artery stenosis: A randomized controlled trial of conventional versus MicroNet™-covered stent use in percutaneous neuroprotected carotid artery revascularization: Peri-procedural and 30-day diffusion-weighted magnetic resonance imaging and clinical outcomes Andrey Karpenko, Pavel Ignatenko et al.
LINC 2020
“OPTIMAl endovascular sequestration of high-risk carotid plaque using the CGuard™ MicroNet™–covered embolic prevention stent system in consecutive patients with sym--ptoms or signs of carotid stenosis-related brain injury: An intravascular ultrasound – controlled investigator-initiated multcentric multi-specialty study - CGuard™ OPTIMA” Prof. Piotr. Musialek
LINC 2020
Accumulating long‑term evidence for MicroNet™‑covered stent safety, efficacy and durability in primary and secondary stroke prevention: 5-year data from the PARADIGM-Extend prospective academic trial Prof. Piotr Musialek, et al
LINC 2020
“Immediate and one-month results from a prospective real-world multicentre clinical practice of CAS using the CGuard embolic prevention system: the IRONGUARD 2 study”. Dr. Pasqualino Sirignano, Prof Francesco Speziale
VEITH Symposium 2019
Update On The CGuard™ MicroNet™ Covered Stent For CAS: Longer-Term Results: Advantages And Are There Late Downsides Like ISR Or Late Thrombosis? Prof. Piotr Musialek
VEITH Symposium 2019
Preliminary Results From A Prospective Real - World Multicenter Clinical Practice Of CAS Using The CGuard EPS: The IRONGUARD 2 Study
SIVEC 2019
New data in carotid disease: CGuard MicroNet™-Covered Embolic Prevention Stent - State of the Art, Prof. Piotr Musiałek
TCT 2019
MicroNet™-Covered Self-EXpandableSTentIn High-RiskVascular Lesions Beyond The CArotidBifurcation: The EXTRA-GUARD Multi-centerMulti-specialty Study. Prof. Piotr Musialek
CIRSE 2019
Initial Clinical Study of the New CGuard™ MicroNet™ ® covered Carotid Stent: “One Size Fits All” In vitro testing and initial Clinical Results Christian Wissgott MD
PARADIGM-Extend Prospective Academic Trial
Supported K/ZDS/007819 (Jagiellonian University Medical College) Accumulating long-term evidence for MicroNet™-covered stent safety and stroke prevention efficacy Prof. Piotr Musiałek
ESC Congress 2019 Essential Update
Carotid Disease 2019 Prof. Piotr Musiałek
Initial Clinical Study of the New CGuard™ MicroNet™® covered Carotid Stent:
“One Size Fits All” In-vitro testing and initial Clinical Results Christian Wissgott MD
The SIBERIA Trial – CGuard™ MicroNet™® Covered Stent vs. AcculInk™
Basal, 30d DW-MRI and 1y Clinical Evaluation in 100 RandomIzed pAtients,” Per-Protocol Interim Results in a Randomized DW-MRI Controlled Study of Carotid Artery Revascularization using a MicroNet™ Mesh Stent Drs. Karpenko A, Ignatenko P
PARADIGM-EXTEND Prospective Academic Trial Of CGuard™ MicroNet™-Covered Self-Expandable Stent System
Cumulative 3-Year Clinical And Duplex Ultrasound Evidence For Safety, Efficacy And Durability Of Stroke Prevention Prof. Piotr Musialek
“Results of a Multicenter Italian Registry of Real World CAS with the C-Guard Mesh Covered Stent: the IRONGUARD 2 Study”
Prof. Francesco Speziale, Dr. Wassim Mansour
VEITHsymposium 2018
Results of a multicenter italian registry of real world CAS with the C-Guard mesh covered stent: the IRONGUARD 2 Study Drs. Francesco Speziale, Laura Capoccia
Read more >
VEITHsymposium 2018
2 0 1 8 Update On Results With The CGuard™ MicroNet™ Covered Stent (InspireMD) For CAS: Does It Prevent Strokes: Does It Cause ISR Or Other Long-Term Problems: Can It Have Value In Other Vascular Beds? Piotr Musialek, MD DPhil
Read more >
VEITHsymposium 2018
Clinical results and mechanical properties of a novel double-layered carotid stent (CGUARD) Christian Wissgott MD
Read more >
Current Status of Carotid Interventions
Role of CAS in 2018
Carotid Angioplasty Evolution – 2018
Accumulating two-year clinical and duplex ultrasound evidence from the CGuard PARADIGM- Extend prospective academic trial: Durability of stroke prevention
TCT 2016
Twelve-month Safety and Efficacy of CGuard™ MicroNet™–covered Embolic Prevention Stent Routine Use to Perform Carotid Revascularization: TCT 2016 Featured Research PARADIGM All-Comer Prospective Academic Study
CIRSE 2016
CGuard™ EPS System – My experience in treatment of carotid lesions: Mechanical behavior and clinical results PD Dr. Christian Wissgott
Webcast Recording
Webcast Recording: Late Breaking Presentation from EuroPCR '16 CGuard and PARADIGM 101 with Prof. Musialek
EuroPCR 2016
CGuard Late Breaking Trial Presentation at EuroPCR: Novel PARADIGM in carotid revascularization by Dr. Musialek
LINC 2016
Carotid artery revascularization using CGuard™ MicroNet™-Covered Embolic Prevention Stent System: A Change in the Game
VEITHsymposium 2015
MicroNet™ Covered Embolic Prevention Carotid Stent System: From CARENET and PARADIGM Studies to Routine Clinical Practice
EuroPCR 2015
Endovascular management of highly calcified carotid lesions presented at EuroPCR 2015 by Dr. Adam Mazurek
EuroPCR 2015
The PARADIGM Study presented at EuroPCR 2015 by Dr. Piotr Musialek
EuroPCR 2015
CARENET update presented at EuroPCR 2015 by Dr. Joachim Schofer
LINC 2015
CARENET trial 6 month update presented at LINC 2015 by Dr. Piotr Musialek
